Innovexia Pharma Llp - Due diligence report
A 360° intelligence report on Innovexia Pharma Llp: trust score, financial health, credit view, compliance, directors, growth and distress s…
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Innovexia Pharma Llp — 360° Intelligence Report
Generated from MCA filings & public recordsInnovexia Pharma Llp is assessed as Low Risk with a Trust Score of 88/100. Innovexia Pharma Llp is an active limited liability partnership incorporated in 2020, operating in the Home Appliances sector. Processed financial statements are not yet available for trend analysis. Based on MCA filings and public records, it currently shows a low compliance risk and an unassessed financial risk profile.
Report generated on 14 Oct 2026 from the latest processed filings. Innovexia Pharma Llp snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
Score Card
Higher is safer · rule-based & explainableFinancial Intelligence Dashboard
No processed financialsCredit & Compliance Intelligence
Why the scores are what they are- Financial statements needed for a credit view.
Charges position: 0 open (-) · 0 satisfied (-).
- Company status is Active as per MCA.
- No balance-sheet filing date on record.
Director Intelligence
Stability score: 95/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| PARVINDER KAUR JARNAIL SINGH THINDE | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| MANDEEP KAUR JARNAIL SINGH THIND | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 2 directors on the board.
- No disqualified or deactivated DINs.
- Stable board - no exits in 3 years.
- Average tenure above 5 years.
Ownership & Group Intelligence
Full shareholding pattern, group structure & capital events →
Risk Intelligence Center
Growth N/A · Distress 90Stakeholder Verdicts
Vendor · Banker · Investor- Statutory record is clean.
- No distress signals on file.
- No financials on record - ask for audited statements.
- No filed financials - rely on banking statements and GST data.
- No existing security registered - first-charge position available.
- Compliance record supports lending.
- No clear growth signals in the filed years.
- Request management accounts - public filings insufficient.
- Management team looks stable.
MCA Filings & Events Timeline
Latest 3 eventsKey Observations
Auto-generated from the data above| Company | CIN | Location |
|---|---|---|
| Soyleaf India Private Limited | U01100MH2021PTC372440 | Thane, Maharashtra |
| Santu Infraprojects Private Limited | U43299MH2023PTC411118 | Thane, Maharashtra |
| RENAYE ORGANIC LLP | AAV-0799 | Thane, Maharashtra |
| Rudraya E-Commerce Private Limited | U52320MH2016PTC285158 | Thane, Maharashtra |
| SARASWATI SPACES LLP | AAG-6433 | Thane, Maharashtra |
| Uniteam Infra Private Limited | U74999MH2017PTC291196 | Thane, Maharashtra |
| Karan Shejwal And Enterprises Private Limited | U50400MH2019PTC325464 | Thane, Maharashtra |
| SVANABHA INDUSTRIES LLP | AAZ-3613 | Thane, Maharashtra |
| Ambercare Hospital Private Limited | U85300MH2018PTC305870 | Thane, Maharashtra |
| Whoopeedice Private Limited | U74999MH2018PTC307346 | Thane, Maharashtra |
Who Uses This Report
CA · CS · Banker · Investor · VendorVerify Innovexia Pharma Llp before audits and certifications: compliance score 90/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Track statutory health of Innovexia Pharma Llp: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Current banker verdict: Favourable lending indicators. Credit risk score pending financials, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investor view: Mixed indicators. Growth score n/a, margin trends, ownership structure and peer set for Innovexia Pharma Llp - screening before a deeper diligence.
Vendor verdict: Favourable indicators. Trust score 88/100, distress signals and MSME payment-delay disclosures - know whether Innovexia Pharma Llp pays its suppliers before you extend credit terms.
Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Innovexia Pharma Llp - groundwork for KYC, onboarding and disputes.
Frequently Asked Questions
Is Innovexia Pharma Llp an active company?
Innovexia Pharma Llp has MCA status “Active” with a compliance score of 90/100 (Low Risk).
Is Innovexia Pharma Llp financially healthy?
Processed financial statements are not yet available for Innovexia Pharma Llp, so its financial health is unassessed.
Should I do business with Innovexia Pharma Llp?
Its overall Trust Score is 88/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Innovexia Pharma Llp?
See the directors and ownership sections above for board and shareholding detail. 2 active director(s) are on record.
Does Innovexia Pharma Llp have loans or charges against its assets?
No charges are registered against this company - an unencumbered balance sheet.
Is Innovexia Pharma Llp up to date with its ROC filings?
No balance-sheet filing date on record. Overall compliance score: 90/100 (Low Risk).
Is it risky to lend to Innovexia Pharma Llp?
Filed financial statements are needed for a credit view - ask the company for audited statements and bank statements.